Disease ID | Disease name | Source of annotation with LCK | OMIM link | Number of associated genes | genes |
---|---|---|---|---|---|
615758 | IMMUNODEFICIENCY 22 | ClinVar, OMIM, HUMSAVAR | link to OMIM | 1 | LCK |
Download the gene annotation in CSV format
KEGG pathway | KEGG ID | KEGG IC |
---|---|---|
Natural killer cell mediated cytotoxicity | hsa04650 | 5.53 |
T cell receptor signaling pathway | hsa04660 | 6.01 |
Osteoclast differentiation | hsa04380 | 5.64 |
Primary immunodeficiency | hsa05340 | 7.52 |
NF-kappa B signaling pathway | hsa04064 | 6.21 |
HTLV-I infection | hsa05166 | 4.59 |
REACTOME pathway | REACTOME ID | REACTOME IC |
---|---|---|
Generation of second messenger molecules | R-HSA-202433 | 7.34 |
PD-1 signaling | R-HSA-389948 | 7.62 |
Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 7.81 |
CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 8.59 |
PI3K/AKT activation | R-HSA-198203 | 6.32 |
Signaling by Interleukins | R-HSA-449147 | 4.71 |
GPVI-mediated activation cascade | R-HSA-114604 | 7.18 |
Immune System | R-HSA-168256 | 2.37 |
Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 7.05 |
PI3K events in ERBB2 signaling | R-HSA-1963642 | 6.37 |
Cell surface interactions at the vascular wall | R-HSA-202733 | 6.32 |
Cytokine Signaling in Immune system | R-HSA-1280215 | 3.74 |
Platelet activation, signaling and aggregation | R-HSA-76002 | 5.15 |
Downstream signal transduction | R-HSA-186763 | 4.65 |
GAB1 signalosome | R-HSA-180292 | 6.31 |
The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 8.18 |
Signaling by ERBB4 | R-HSA-1236394 | 4.7 |
Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 8.59 |
Adaptive Immune System | R-HSA-1280218 | 3.19 |
PI-3K cascade:FGFR2 | R-HSA-5654695 | 6.37 |
Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 4.95 |
Host Interactions of HIV factors | R-HSA-162909 | 5.99 |
Nef Mediated CD4 Down-regulation | R-HSA-167590 | 9.81 |
PIP3 activates AKT signaling | R-HSA-1257604 | 6.37 |
PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.37 |
PI-3K cascade:FGFR1 | R-HSA-5654689 | 6.37 |
Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 7.73 |
CTLA4 inhibitory signaling | R-HSA-389513 | 8.52 |
HIV Infection | R-HSA-162906 | 5.22 |
NGF signalling via TRKA from the plasma membrane | R-HSA-187037 | 4.51 |
CD28 co-stimulation | R-HSA-389356 | 7.98 |
Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.59 |
CD28 dependent Vav1 pathway | R-HSA-389359 | 9.4 |
Costimulation by the CD28 family | R-HSA-388841 | 6.56 |
Signaling by FGFR4 | R-HSA-5654743 | 4.69 |
Downstream signaling of activated FGFR3 | R-HSA-5654708 | 4.71 |
Signaling by FGFR3 | R-HSA-5654741 | 4.69 |
Infectious disease | R-HSA-5663205 | 4.47 |
Regulation of KIT signaling | R-HSA-1433559 | 8.98 |
Downstream TCR signaling | R-HSA-202424 | 7.01 |
Signaling by FGFR | R-HSA-190236 | 4.67 |
PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 6.56 |
Diseases of signal transduction | R-HSA-5663202 | 4.89 |
Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 4.03 |
Interleukin-2 signaling | R-HSA-451927 | 5.05 |
PECAM1 interactions | R-HSA-210990 | 9.4 |
Innate Immune System | R-HSA-168249 | 3.17 |
Signaling by SCF-KIT | R-HSA-1433557 | 4.73 |
Signaling by ERBB2 | R-HSA-1227986 | 4.66 |
Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 4.62 |
DAP12 signaling | R-HSA-2424491 | 4.64 |
Downstream signaling of activated FGFR1 | R-HSA-5654687 | 4.71 |
Downstream signaling of activated FGFR2 | R-HSA-5654696 | 4.71 |
Signaling by EGFR | R-HSA-177929 | 4.59 |
Nef and signal transduction | R-HSA-164944 | 9.98 |
Disease | R-HSA-1643685 | 3.33 |
Signalling by NGF | R-HSA-166520 | 4.23 |
Signaling by FGFR2 | R-HSA-5654738 | 4.68 |
Signaling by FGFR1 | R-HSA-5654736 | 4.69 |
PI3K events in ERBB4 signaling | R-HSA-1250342 | 6.37 |
TCR signaling | R-HSA-202403 | 6.64 |
PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.37 |
DAP12 interactions | R-HSA-2172127 | 4.56 |
Downstream signaling of activated FGFR4 | R-HSA-5654716 | 4.71 |
Signaling by PDGF | R-HSA-186797 | 4.53 |
Hemostasis | R-HSA-109582 | 3.98 |
Signal Transduction | R-HSA-162582 | 1.78 |
GO term | GO ID | GO IC |
---|---|---|
protein C-terminus binding | GO:0008022 | 4.5 |
phosphatase activity | GO:0016791 | 4.11 |
purine ribonucleoside triphosphate binding | GO:0035639 | 2.22 |
enzyme binding | GO:0019899 | 2.27 |
phosphoric ester hydrolase activity | GO:0042578 | 3.82 |
small molecule binding | GO:0036094 | 1.89 |
binding | GO:0005488 | 0.18 |
phosphatidylinositol 3-kinase activity | GO:0035004 | 5.49 |
heterocyclic compound binding | GO:1901363 | 1.06 |
purine nucleoside binding | GO:0001883 | 2.22 |
nucleoside binding | GO:0001882 | 2.21 |
phosphatidylinositol-4,5-bisphosphate 3-kinase activity | GO:0046934 | 5.61 |
phosphatidylinositol 3-kinase binding | GO:0043548 | 6.41 |
CD4 receptor binding | GO:0042609 | 8.13 |
nucleoside phosphate binding | GO:1901265 | 1.96 |
nucleotide binding | GO:0000166 | 1.96 |
phosphatidylinositol bisphosphate kinase activity | GO:0052813 | 5.56 |
transferase activity | GO:0016740 | 1.95 |
non-membrane spanning protein tyrosine kinase activity | GO:0004715 | 5.91 |
protein tyrosine kinase activity | GO:0004713 | 4.54 |
ribonucleoside binding | GO:0032549 | 2.22 |
purine nucleotide binding | GO:0017076 | 2.19 |
protein kinase activity | GO:0004672 | 3.27 |
ATP binding | GO:0005524 | 2.43 |
hydrolase activity | GO:0016787 | 1.9 |
SH2 domain binding | GO:0042169 | 6.34 |
ATPase binding | GO:0051117 | 5.41 |
kinase activity | GO:0016301 | 2.93 |
hydrolase activity, acting on ester bonds | GO:0016788 | 3.1 |
protein kinase binding | GO:0019901 | 3.44 |
kinase binding | GO:0019900 | 3.32 |
protein phosphatase binding | GO:0019903 | 4.93 |
phosphatase binding | GO:0019902 | 4.63 |
protein domain specific binding | GO:0019904 | 3.32 |
glycoprotein binding | GO:0001948 | 5.11 |
CD8 receptor binding | GO:0042610 | 9.05 |
adenyl nucleotide binding | GO:0030554 | 2.4 |
carbohydrate derivative binding | GO:0097367 | 2.03 |
transferase activity, transferring phosphorus-containing groups | GO:0016772 | 2.77 |
catalytic activity | GO:0003824 | 1.05 |
protein serine/threonine phosphatase activity | GO:0004722 | 5.58 |
phosphoprotein phosphatase activity | GO:0004721 | 4.55 |
phosphotransferase activity, alcohol group as acceptor | GO:0016773 | 3.08 |
adenyl ribonucleotide binding | GO:0032559 | 2.41 |
identical protein binding | GO:0042802 | 2.63 |
protein binding | GO:0005515 | 0.46 |
organic cyclic compound binding | GO:0097159 | 1.05 |
purine ribonucleotide binding | GO:0032555 | 2.2 |
receptor binding | GO:0005102 | 2.43 |
purine ribonucleoside binding | GO:0032550 | 2.22 |
ribonucleotide binding | GO:0032553 | 2.19 |